Characteristics | n (175) | POPF (30) | \({X}^{2}\) | P value |
---|---|---|---|---|
Gender | ||||
Male | 79 (45%) | 15 (50%) | 0.34 | 0.55 |
Female | 96 (45%) | 15 (50%) | ||
Abdominal symptom | ||||
Presence | 107 (61%) | 19 (63%) | 0.07 | 0.78 |
Absence | 68 (39%) | 11 (37%) | ||
Hypertension | ||||
Presence | 41 (23%) | 8 (26.6%) | 0.21 | 0.64 |
Absence | 134 (77%) | 22 (73.3%) | ||
Diabetes | ||||
Presence | 35 (20%) | 10 (33.3%) | 2.00 | 0.04 |
Absence | 140 (80%) | 20 (66.6%) | ||
Previous abdominal surgery | ||||
Presence | 34 (19%) | 5 (16.6%) | 0.17 | 0.67 |
Absence | 141 (81%) | 25 (83.3%) | ||
ASA score | ||||
Score (≤2) | 123 (70%) | 15 (50%) | 7.13 | 0.01 |
Score (>2) | 52 (30%) | 15 (50%) | ||
Surgical techniques | ||||
Laparoscopic spleen-preserving | 17 (9.7%) | 1 (3.3%) | 3.62 | 0.30 |
Laparoscopic splenectomy | 19 (10.8%) | 2 (6.6%) | ||
Open spleen-preserving | 18 (10.2%) | 5 (16.6%) | ||
Open splenectomy | 121 (69.1%) | 22 (73.3%) | ||
Management of the pancreatic stump | ||||
Linear incision closure | 120 (68.5%) | 26 (86.6%) | 4.42 | 0.10 |
Electrosurgical dissection | 30 (17.1%) | 3 (10%) | ||
Electrosurgical dissection and main pancreatic duct ligation | 24 (13.7%) | 1 (3.3%) | ||
Cystadenoma | 64 (36.5%) | 9 (30%) | ||
Pseudopapillary neoplasm | 14 (8%) | 4 (13.3%) | ||
Pathological type | ||||
Pancreatic cancer | 63 (36%) | 11 (36.6%) | 1.07 | 0.78 |
Neuroendocrine tumors | 24 (13.7%) | 4 (13.3%) | ||
Other | 9 (5%) | 2 (6.6%) |